Trastuzumab Deruxtecan (T-Dxd) in Chinese Patients (pts) with Previously Treated HER2 Mutant Non-Small Cell Lung Cancer (NSCLC): Primary Analysis from the Phase 2 DESTINY-Lung05 (DL-05) Trial
CANCER RESEARCH（2024）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要